Tartaric Acid

Apexbio Technology LLC ENMD-2076 L-(+)-Tartaric acid 1291074-87-7 50mg

ENMD-2076 L- plus -Tartaric acid is a small-molecule inhibitor targeting Aurora kinase A and B It is designed to inhibit the activity of these kinases thereby regulating cell cycle progression and mitotic processes ENMD-2076 L- plus -Tartaric acid exerts its biological activity primarily through the inhibition of Aurora kinase A and B with IC50 values of approximately 14 nM and 350 nM respectively In cell-based studies ENMD-2076 inhibits various breast cancer cell lines suppresses colony formation and induces G2 phase cell-cycle arrest Based on these pharmacological properties ENMD-2076 L- plus -Tartaric acid holds research potential in breast and hematological malignancies

Apexbio Technology LLC ENMD-2076 L-(+)-Tartaric acid 1291074-87-7 5mg

ENMD-2076 L- plus -Tartaric acid is a small-molecule inhibitor targeting Aurora kinase A and B It is designed to inhibit the activity of these kinases thereby regulating cell cycle progression and mitotic processes ENMD-2076 L- plus -Tartaric acid exerts its biological activity primarily through the inhibition of Aurora kinase A and B with IC50 values of approximately 14 nM and 350 nM respectively In cell-based studies ENMD-2076 inhibits various breast cancer cell lines suppresses colony formation and induces G2 phase cell-cycle arrest Based on these pharmacological properties ENMD-2076 L- plus -Tartaric acid holds research potential in breast and hematological malignancies